I am sure col will point out the obvious poor peformance of the sulfides at Syama and the poor recovery, but i have read the notes accompanying and all is good as when solely ug ore used, recoveries above 85%.
And yes we made a loss for the six months but that is to be expected seeing , as col has pointed out, we are spending lots on getting it all going as planned.
So nothing new but a little more detail of why and how. Its probably the first time i have read it in its entirity and will sleep well knowing that things are about to turn big time.
Tabakoroni has me excited .
The only thing that i have yet to get my head around, is total spend on Syama to date, but will leave that to another night when i am not so sleepy.
And i am glad they released after close Friday, so that all can digest the numbers and evaluate the situation, without those pesky people who only look at the loss and dont dig deeper into the situation crying panic stations.
Christopher
- Forums
- ASX - By Stock
- Ann: Financial Report six months ended 31 December 2018
I am sure col will point out the obvious poor peformance of the...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RSG (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $1.543B |
Open | High | Low | Value | Volume |
40.5¢ | 40.5¢ | 37.5¢ | $22.35M | 57.19M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14881 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 668567 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 1.245 |
14 | 458433 | 1.240 |
12 | 312067 | 1.235 |
6 | 139692 | 1.230 |
6 | 131961 | 1.225 |
Price($) | Vol. | No. |
---|---|---|
1.250 | 371388 | 17 |
1.255 | 220916 | 10 |
1.260 | 134993 | 10 |
1.265 | 104166 | 6 |
1.270 | 38032 | 5 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
RSG (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online